Lygos provides biotechnology solutions for today’s renewable chemical challenges.
Lygos is providing biotechnology solutions for today’s renewable chemical challenges. They engineer microbes to convert sugars into high-value, industrial chemicals, targeting compounds where biological production is cost-advantaged over petrochemical production. The company's throughput screening and strain construction facilitate the rapid optimization of pathways to convert cheap and renewable feedstock to high-value chemicals.Founded in 2011, Lygos is headquartered in Berkeley, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 29, 2019 | Series B | $5M | 1 |
|
— | Detail |
Jun 3, 2019 | Grant | $2M | 1 |
![]() |
— | Detail |
Mar 11, 2019 | Grant | $750K | 1 | — | — | Detail |
Sep 7, 2018 | Grant | $2M | 1 | — | — | Detail |
Feb 18, 2015 | Grant | $1.42M | 1 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
Yes | Series B |
![]() |
Yes | Grant |
![]() |
— | Grant |